Company Ticker News November 4, 2021Medexus Schedules Second Quarter Fiscal 2022 Conference Call 0 0 Share
Press Release November 1, 2021Medexus Pharmaceuticals Announces Type A Meeting with FDA Granted for Treosulfan 0 0 Share
Press Release September 22, 2021Medexus Announces Expanded Availability of Trecondyv® (treosulfan) in Canada 0 0 Share
Press Release September 17, 2021Medexus Holds Annual and Special Meeting of Shareholders and Announces Election of Board of Directors 0 0 Share
Press Release September 2, 2021Medexus Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference 0 0 Share
Company Ticker News August 19, 2021Medexus: Commercial And Late-Stage Rare Disease Pharmaceuticals 0 0 Share
Company Ticker News August 17, 2021Medexus Pharmaceuticals' (MEDXF) CEO Ken d'Entremont on Q1 2022 Results - Earnings Call Transcript 0 0 Share
Company Ticker News August 17, 2021Medexus Pharmaceuticals Reports Financial and Operational Results for First Quarter Fiscal 2022 0 0 Share
Press Release August 12, 2021Medexus Completes Enrollment in Phase 4 Clinical Trial of IXINITY® Targeting Label Expansion for Pediatric Hemophilia B Patients 0 0 Share
Company Ticker News August 11, 2021Medexus Pharmaceuticals to Present at the SNN Network Summer Virtual Event on Thursday, August 19, 2021 0 0 Share
